Patient Guide: Testing Two Different Drugs (Sacituzumab-govitecan and Trastuzumab-deruxtecan) Combinations Prescribed in an Alterning Pattern to Patients With Metastatic or Locally Advanced Triple-negative Breast Cancer

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 2 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT07151586
Status: UPCOMING
Condition: Triple Negative Breast Neoplasms, Neoplasm Metastasis, HER 2 Low-expressing Breast Cancer
Phase: PHASE2

Find a Study Location Near You

This study is available at 2 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Marseille,
  • Villejuif,

Loading interactive enrollment tools...

The full interactive experience will load momentarily